Natural Treatments For Prostate Cancer
At Immunity Therapy Center, we utilize a variety of alternative cancer treatments to strengthen your immune system while directly targeting your cancer cells. We take a holistic approach to prostate cancerand focus on the overall health of our patients.
We offer a variety of options for holistic treatment for prostate cancer such as Cryoablation Therapy and intravenous solutions . As part of our alternative therapy, were big advocates in the idea that your attitude truly affects the results of your cancer treatment program. We find patients with positive attitudes, and hope for their cancer therapy, see more successful results.
If you are interested in alternative prostate cancer treatment in Mexico, reach out to us today. Tijuana has become a hub for alternative cancer treatment centers, paving the way for holistic care to become part of the cancer treatment dialogue everywhere. Were proud to be one of the leaders who offer prostate cancer natural treatment options.
Were passionate about providing a customized alternative therapy treatment plan for each of our patients. If you or your loved one have tried mainstream medicine only to have relapsed or been economically drained, were here for you. Alternative medicine can be the answer to the perfect holistic treatment for prostate cancer.
Treatments For Liver Cancer
Several options are currently used for treating cancer that has metastasized to the liver. In most cases treatment will be palliative. This means that it will be used to control symptoms of the cancer and prolong life but will not likely result in cure. Generally, the choice of treatments will depend on:
- the persons age and overall health
- the size, location, and number of metastatic tumors
- location and type of the primary cancer
- the types of cancer treatment the patient had in the past
Stem Cell Or Bone Marrow Transplant
A stem cell transplant, sometimes called bone marrow transplant, replaces damaged blood-forming cells with healthy ones. The procedure takes place following large-dose chemotherapy or radiation therapy to kill cancer cells and to stop your stem cells from producing cancerous cells.
Stem cell transplants can be used for several types of cancer, including multiple myeloma and some kinds of leukemia.
Read Also: Holistic Treatment For Prostate Cancer
The Stages Of Prostate Cancer: What You Need To Know
After a prostate cancer diagnosis, your oncologist will refer to the stage of your cancer. All cancers are categorized into four distinct stages, each of which identifies the progress of the growth of cancerous cells within clinically defined standards. These stages help doctors determine the most appropriate care for each patient based on his or her condition, and can also provide easy-to-understand context for your diagnosis. Learn more about the stages of prostate cancer, how each stage will affect your treatment plan and the survival rates for each stage, then contact Regional Cancer Care Associates to schedule a consultation.
Can Prostate Cancer Spread
Medically Reviewed by: Dr. BautistaUpdated on: November 18, 2019
Like other cancers, prostate cancer can spread if the cancer cells grow out of control. At ITC, we treat all different types of cancer and know that patients often have a lot of questions surrounding their diagnosis.
We often are asked what is prostate cancer? Can prostate cancer spread? How is it diagnosed? And more. At Immunity Therapy Center, we know that each diagnosis is unique and every patient is different which is why we focus on a holistic approach to prostate cancer. And we believe that when patients have the knowledge, theyre more likely to take control of their health.
To give you the knowledge to prepare, lets take a closer look at prostate cancer, what symptoms to look for, and how it can spread.
Read Also: Vitamins And Supplements For Prostate Health
What Is A 5
A relative survival rate compares people with the same type and stage of cancer to people in the overall population. For example, if the 5-year relative survival rate for a specific stage of prostate cancer is 90%, it means that men who have that cancer are, on average, about 90% as likely as men who dont have that cancer to live for at least 5 years after being diagnosed.
Akt Abrogation Partially Reverses The E
We next sought to determine whether the chemoprotective effect of E-cadherin related to the activation of prosurvival intermediary kinases. Phosphorylated ERK increased in DU-L-derived, E-cadherin-expressing hepatic tumor nodules upon chemotherapy exposure. On the other hand, the nodules that did not express E-cadherin failed to show p-ERK staining this was similar to the staining in the absence of chemotherapy challenge. Phosphorylated AKT was undetectable in vivo, which could be due to transient activation or limited detection levels. However, both AKT1 and AKT2, two primary AKT isoforms involved in cell survival, increased significantly in E-cadherin-expressing hepatic tumor nodules . Given that ERK also acts during induction of EMT, which leads to E-cadherin down-regulation and would thus confound analyses, we subsequently disrupted the PI3K-AKT kinase cascade by the PI3K inhibitor LY294002. LY294002 itself did not affect the tumor cells, either by decreasing burden or by inducing apoptosis. When LY294002 was added to PTX, dramatically more cleaved caspase-3 was noted in the tumor nodules abrogation of AKT was synergistic with PTX treatment . This synergistic effect of AKT abrogation was also found in DU-H splenic tumor nodules, which did not respond to chemotherapy alone . These findings indicated that abrogation of PI3K-AKT at least partially reversed E-cadherin-related protection in vivo in addition to its effect in vitro.
You May Like: Prostate Cancer Erectile Dysfunction Treatment
Chances Of Developing Metastatic Prostate Cancer
About 50% of men diagnosed with local prostate cancer will get metastatic cancer during their lifetime. Finding cancer early and treating it can lower that rate.
A small percentage of men aren’t diagnosed with prostate cancer until it has become metastatic. Doctors can find out if it’s metastatic cancer when they take a small sample of the tissue and study the cells.
What Is The Prostate
The prostate is a small gland that only men have. Normally, the prostate is about the size of a walnut. The prostate is located underneath the bladder and in front of the rectum. The prostate makes and stores fluid that is part of semen. This fluid is released from a mans penis during ejaculation.
The male hormone, testosterone, helps the prostate gland work as it should. Nerves to the penis, which are important in producing and maintaining an erection, run very close to the prostate. The prostate completely encircles the tube that carries urine from the bladder to the penis, called the urethra. If the prostate grows too big, it can block the flow of urine from the bladder, making it hard for a man to urinate.
You May Like: How Big Is A Normal Prostate
Asian Or Pacific Islander Ethnic Background Was Associated With Favorable Os
Several studies have reported that for localized and locally advanced PCa patients, Black men consistently have a higher mortality rate than do men of other ethnicities. One possible reason for this finding is that Black men are less likely to be treated with a curative intent than are White men . However, in our study, Black men presented survival times similar to those of White men. This phenomenon might be explained by the fact that in the metastatic stage, there are few proactive treatments available to significantly change the oncological outcome of these patients. Interestingly, our study demonstrated that patients with an Asian or Pacific Islander background were associated with a better OS than White men, which is consistent with previous reports showing that Asian men have superior survival in de novo metastatic PCa than do men of other races . Therefore, genomic diversities rather than treatments are most accountable for the different survival times between races . It is known that allelic imbalance at 13q14 and 13q21 is significantly higher in Japanese patients than in Caucasians . The frequency of the TMPRSS2-ERG fusion in Chinese patients is significantly lower than those patients from Western countries . Furthermore, differences in diet and other lifestyle factors may also affect survival .
Overview Of The Staging System
After a thorough assessment by your oncologist, your cancer will be assigned a stage between I and IV. Prostate cancer stages are based on the American Joint Committee on Cancer TNM system. Using the TNM system, your oncologist:
- Examines the tumor
- Determines if the cancer has spread to any lymph nodes
- Assesses whether the cancer has metastasized
- Considers the prostate-specific antigen level from blood testing
- Assigns a grade group based on how abnormal the cancer appears under a microscope
With this information in mind, you can better understand how stages are assigned and what they mean for patients in general.
Recommended Reading: What Kind Of Pain Does Prostate Cancer Cause
What Causes Bladder Cancer And Am I At Risk
Each year, about 83,730 new cases of bladder cancer will be diagnosed in the United States. It affects more men than women and the average age at diagnosis is 73.
Cigarette smoking is the biggest risk factor for bladder cancer. About half of all bladder cancers are caused by cigarette smoking. Other risk factors for developing bladder cancer include: family history, occupational exposure to chemicals , previous cancer treatment with cyclophosphamide, ifosfamide, or pelvic radiation, the medication pioglitazone, exposure to arsenic , aristolochic , bladder infections caused by schistosoma haematobium, not drinking enough fluids, a genetic condition called Lynch Syndrome, a mutation of the retinoblastoma gene or the PTEN gene. and neurogenic bladder and the overuse of indwelling catheters.
The Future Of Psma Pet
This is a solid study and reflects the real-world experience with PSMA PET-CT in other countries, Dr. Pomper said. Because there are several PSMA-targeted tracers, a next step will be to have them approved for use in the United States outside of clinical trials, he added.
He predicted that, eventually, the different PSMA tracers will be tested head to head.
The Australian trial adds to a growing body of research on improving the detection of metastatic tumors in men with prostate cancer. One imaging agent, fluciclovine F18 which targets prostate cancer cells in a different way than PSMA-targeted tracersis already approved in the United States for use in men with previously treated prostate cancer that appears to be progressing .
PSMA PET-CT is also being studied in this group of men, Dr. Shankar said. One small clinical trial that directly compared PSMA PET-CT with fluciclovine F18 PET-CT showed that the PSMA-targeted scan found more metastatic tumors, regardless of their location. NCI is funding a similar but larger clinical trial.
Dr. Pomper noted that PSMA also is found at relatively high levels in the vasculature of a number of other cancersincluding kidney, thyroid, and breastso hes hopeful that PSMA PET-CT might be useful beyond prostate cancer.
Urologists and radiation oncologists in many places are already ordering this scan as the standard of care, he said.
Read Also: How Many Men Die Of Prostate Cancer
Survival Rates For Prostate Cancer
Survival rates can give you an idea of what percentage of people with the same type and stage of cancer are still alive a certain amount of time after they were diagnosed. These rates cant tell you how long you will live, but they may help give you a better understanding of how likely it is that your treatment will be successful.
Keep in mind that survival rates are estimates and are often based on previous outcomes of large numbers of people who had a specific cancer, but they cant predict what will happen in any particular persons case. These statistics can be confusing and may lead you to have more questions. Talk with your doctor about how these numbers may apply to you, as he or she is familiar with your situation.
Types Of Imaging Studies
If your doctor suspects your cancer might be spreading, they will likely order more imaging tests. A common imaging workup may include a bone scan and a CT scan of the abdomen and pelvis. An MRI might be done as well. Some research centers are also using magnetic MRIs or PET scans to further refine the staging of prostate cancer.
Prostate Cancer Doctor Discussion Guide
Get our printable guide for your next doctor’s appointment to help you ask the right questions.
Also Check: Benign Prostatic Hypertrophy With Outflow Obstruction
What Tests Will I Have If My Doctor Suspects Bladder Cancer Or Another Urinary Problem
Your doctor will want to analyze your urine to determine if an infection could be a cause of your symptoms. A microscopic examination of the urine, called cytology, will look for cancer cells.
A cystoscopy is the main procedure to identify and diagnose bladder cancer. In this procedure, a lighted telescope is inserted into your bladder from the urethra to view the inside of the bladder and, when done under anesthesia, take tissue samples , which are later examined under a microscope for signs of cancer. When this procedure is done in the doctors office, local anesthesia gel is placed into the urethra prior to the procedure to minimize the discomfort.
If the diagnosis of bladder cancer is made, then the next step is to remove the tumor for detailed staging and diagnosis.
Transurethral resection is a procedure done under general or spinal anesthesia in the operating room. A telescope is inserted into the bladder and the tumor is removed by scraping it from the bladder wall , using a special cystoscope . This procedure is diagnostic as well as therapeutic.
This often can be done as an outpatient procedure, with patients discharged from hospital the same day. After removal, the tumor is analyzed by a pathologist, who will determine the type of tumor, the tumor grade and the depth of invasion. The purpose of the procedure is to remove the tumor and obtain important staging information .
Also Check: Chemo Pill For Prostate Cancer
Watchful Waiting And Active Surveillance
Watchful waiting is an adequate approach in patients who are at low risk of death from prostate cancer because of their limited life expectancy due to severe comorbidities., Watchful waiting resulted in similar overall survival when compared with radical prostatectomy, but disease-specific survival was better in patients who had undergone surgery. For some patients it turns out to be hard to persist on a watchful waiting policy, and many men drop out and seek active treatment within several years, mostly when PSA elevation is noted.
Active surveillance is a novel and fascinating approach to distinguish between patients who are at higher risk and need active therapy and patients who are at low risk for disease progression., This approach avoids the risks of therapy while allowing early detection of those patients who are prone to progress. In these high-risk individuals, delayed active treatment is offered. Periodic monitoring of the PSA serum level, digital rectal exam, and repeated prostate biopsies are performed in patients who are on active surveillance, and active therapy is started when predefined threshold values are reached. This concept makes it possible to offer curative treatment to individuals who are at high risk for disease progression as indicated by active surveillance parameters.
Also Check: How Often Should You Test For Prostate Cancer
You May Like: Prostate Artery Embolization Side Effects
Men With Prostate Cancer Metastasized To The Liver Have Worst Overall Median Survival
Men whose castration-resistant prostate cancer has metastasized to the liver have the worst overall median survival when compared with those with lymph-only, lung, or bone metastases, the largest meta-analysis of its kind has found.1
These results can change the current treatment landscape for men in each of the metastatic subgroups.
Physicians may treat men with liver metastases more aggressively than men if they had bone or liver metastases, lead study author Susan Halabi, PhD, professor of biostatistics at Duke University in Durham, NC, told Cancer Therapy Advisor.
The impetus behind the study was to determine if liver metastases had an impact on survival, which had been suggested in past studies with small numbers of men with liver or lung metastases.
Our understanding of what drives the development of different metastatic patterns of this disease is limited and underscores the need to biopsy patients with recurrences to identify underlying mechanisms and develop novel treatment approaches for men with mCRPC, Dr Halabi reported.
Investigators from 20 United States and international cancer research centers pulled individual patient data on 8820 men enrolled in 9 phase 3 study trials between October 1999 and November 2012: SWOG 9916, TAX 327, Cancer and Leukemia Group B 90401, SWOG 0421, VENICE, Endothelin A Use , READY, MAINSAIL, and SYNERGY.
Metastatic disease was classified as 1 of 2 mutually exclusive groups, non-visceral or visceral disease.
Surgically Removing The Prostate Gland
A radical prostatectomy is the surgical removal of your prostate gland. This treatment is an option for curing prostate cancer that has not spread beyond the prostate or has not spread very far.
Like any operation, this surgery carries some risks.
A recent trial showed possible long-term side effects of radical prostatectomy may include an inability to get an erection and urinary incontinence.
Before having any treatment, 67% of men said they could get erections firm enough for intercourse.
When the men who had a radical prostatectomy were asked again after 6 months, this had decreased to 12%. When asked again after 6 years, it had slightly improved to 17%.
For urinary incontinence, 1% of men said they used absorbent pads before having any treatment.
When the men who had a radical prostatectomy were asked again after 6 months, this had increased to 46%. After 6 years, this had improved to 17%.
Out of the men who were actively monitored instead, 4% were using absorbent pads at 6 months and 8% after 6 years.
In extremely rare cases, problems arising after surgery can be fatal.
Itâs possible that prostate cancer can come back again after treatment. Your doctor should be able to explain the risk of your cancer coming back after treatment, based on things like your PSA level and the stage of your cancer.
After a radical prostatectomy, youâll no longer ejaculate during sex. This means you will not be able to have a child through sexual intercourse.
You May Like: Fla Treatment For Prostate Cancer